# A Single Ascending Dose Study of Safety and Tolerability of STA363 Compared to Placebo in 15 Patients With Chronic Discogenic Low Back Pain

> **NCT03055845** · PHASE1 · COMPLETED · sponsor: **Stayble Therapeutics** · enrollment: 15 (actual)

## Conditions studied

- Low Back Pain

## Interventions

- **DRUG:** STA363
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03055845
- **Lead sponsor:** Stayble Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-27
- **Primary completion:** 2019-08-29
- **Final completion:** 2019-08-29
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03055845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03055845, "A Single Ascending Dose Study of Safety and Tolerability of STA363 Compared to Placebo in 15 Patients With Chronic Discogenic Low Back Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03055845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*